Meng Xu
University of Hawaiʻi at Mānoa(US)University of Hawaii System(US)Peking University(CN)Cancer Center of Hawaii(US)Second Affiliated Hospital of Xi'an Jiaotong University(CN)Second Affiliated Hospital of Jilin University(CN)Central Hospital of Wuhan(CN)Xijing Hospital(CN)Tongji Hospital(CN)First Affiliated Hospital of Jinan University(CN)University of Hawaii Cancer CenterHuazhong University of Science and Technology(CN)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Wnt/β-catenin signaling in development and cancer, Hippo pathway signaling and YAP/TAZ, Immunotherapy and Immune Responses, Brain Metastases and Treatment
Most-Cited Works
- → CD47 blockade triggers T cell–mediated destruction of immunogenic tumors(2015)745 cited
- → Host STING-dependent MDSC mobilization drives extrinsic radiation resistance(2017)465 cited
- → IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway(2019)179 cited
- → Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse(2016)106 cited
- → Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases(2018)99 cited
- → Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases(2018)95 cited